CEO of Threshold Pharmaceuticals Inc. (THLD, Financial) Harold E Selick buys 47,619 shares of THLD on 03/11/2011 at an average price of $2.1 a share.
Threshold Pharmaceuticals Inc. has a market cap of $60 million; its shares were traded at around $1.78 with and P/S ratio of 41.6.
For the complete insider trading history of THLD, click here.
Threshold Pharmaceuticals Inc. has a market cap of $60 million; its shares were traded at around $1.78 with and P/S ratio of 41.6.
Directors and Officers Recent Trades:
- Buy: President and CMO John G Curd bought 11,904 shares of THLD stock on 03/11/2011 at the average price of 2.1. John G Curd owns at least 127,841 shares after this. The price of the stock has decreased by 15.24% since.
- Buy: Sr Director Finance/Controller Joel A Fernandes bought 7,142 shares of THLD stock on 03/11/2011 at the average price of 2.1. Joel A Fernandes owns at least 19,059 shares after this. The price of the stock has decreased by 15.24% since.
- Buy: 10% Owner Gregory P Sands bought 14,910 shares of THLD stock on 03/11/2011 at the average price of 2.1. Gregory P Sands owns at least 94,597 shares after this. The price of the stock has decreased by 15.24% since.
- Buy: 10% Owner James C Gaither bought 10,556 shares of THLD stock on 03/11/2011 at the average price of 2.1. James C Gaither owns at least 40,972 shares after this. The price of the stock has decreased by 15.24% since.
- Buy: 10% Owner Tench Coxe bought 91,766 shares of THLD stock on 03/11/2011 at the average price of 2.1. Tench Coxe owns at least 582,224 shares after this. The price of the stock has decreased by 15.24% since.
For the complete insider trading history of THLD, click here.
